Position summary

As the IT Service Delivery, Associate Director you will be responsible for IT Operations governance of all end-user services and backend infrastructure operations across Calliditas through effective team- and supplier management.

It also includes the application governance of Microsoft365 and related services with focus on adoption and effective backend operations governance. The job is very customer focused with the purpose that through an effective service delivery framework be delivering defined services in a compliant and secure way with a focus on end-user productivity.

You are responsible for developing strategic and tactical roadmaps within the scope of your responsibility. In the position there will occur certain operational activities like performing configuration changes as well as general IT support (incident/problem) and project management. You will be responsible for one direct report, and you report directly to our CIO.

Tasks and responsibilities

The responsibility for this position consists of three main areas;

IT infrastructure services;

• End user services – ServiceDesk, client, print and network management.
• Azure Services(growing)
• IT Service Delivery framework life-cycle management
• Identity management

IT application Governance – Microsoft365 and related services;

• Application lifecycle management – Microsoft365 and related services
• End-user training - Training material life-cycle management

IT Operations:

• Vendor/Supplier service management – service control and service compliance
• Compliance with policies, SOP’s and work instructions
• Human backup to IT operations specialist

Your profile

To thrive and succeed in the role you are an experienced professional and have demonstrable working experience of Microsoft 365 products being optimally used and run and in-depth knowledge of Microsoft Modern Workplace Technologies.

Required competencies;

• Bachelor’s or Master’s degree in Computer Science, Information Technology, Engineering, Economics, or a related field
• Strong experience with management of service contracts
• Solid technical understanding and competence in required areas
• Fluency in Swedish and English, verbal and in writing
• Be able to prioritize and handle varied work tasks
• Confident leadership skills
• Strong written and verbal communication skills, ability to tailor communication to all levels of an organization
• Demonstrated ability to debate ideas/strategy, comfortable managing constructive discussion, and not afraid to challenge the status quo

Meritorious;

• Customer-facing/consulting experience interacting with large-scale distributed data/computing solutions
• ITIL and or Project Manager Certification.
• Master Data management

Reasons to join the Calliditas Team

• Be a part of a global leader in IgA-Nephropathy and a rapidly growing commercial-stage pharmaceutical company within specialty products with strong growth ambitions and a strong pipeline
• Fast paced small company environment
• A unique corporate culture
• Dedicated, experienced and highly skilled colleagues
• Participate on bonus and benefit programs

 Welcome to join the Calliditas Team!

Calliditas has an exclusive partnership with Bossanova People Agency regarding this recruitment. We kindly request that other external recruitment companies refrain from contacting us & Calliditas about this job posting.

About us

Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

Calliditas’ lead product, developed under the name Nefecon, has been granted accelerated approval by the FDA under the trade name TARPEYO® and conditional marketing authorization by the European Commission under the trade name KINPEYGO®.

TARPEYO and KINPEYGO® are the first and only treatments approved for IgA nephropathy by the FDA and EMA, respectively.

Calliditas also has a pipeline in orphan-focused indications. Calliditas is conducting a Phase 2b/3 clinical trial in primary biliary cholangitis and a Phase 2 proof-of-concept trial in head and neck cancer with its NOX inhibitor product candidate, setanaxib.

Calliditas’ common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT).